vs
CXApp Inc.（CXAI）与Ensysce Biosciences, Inc.（ENSC）财务数据对比。点击上方公司名可切换其他公司
Ensysce Biosciences, Inc.的季度营收约是CXApp Inc.的1.8倍（$1.9M vs $1.0M），Ensysce Biosciences, Inc.净利率更高（-147.0% vs -544.1%，领先397.1%），Ensysce Biosciences, Inc.同比增速更快（44.4% vs -38.5%），过去两年Ensysce Biosciences, Inc.的营收复合增速更高（107.9% vs -25.0%）
CXApp Inc.是一家专注于数字工作场所体验解决方案的科技企业，提供员工参与度提升、办公空间优化、访客管理、混合办公协调等云服务产品，主要服务北美、亚太、欧洲的中大型企业客户。
Ensysce Biosciences是一家临床阶段生物技术公司，专注于开发疼痛管理和肿瘤适应症领域的创新前药疗法，其专有平台可降低阿片类药物滥用风险并提升治疗有效性，面向全球医疗医药市场，重点解决未被满足的临床需求。
CXAI vs ENSC — 直观对比
营收规模更大
ENSC
是对方的1.8倍
$1.0M
营收增速更快
ENSC
高出82.9%
-38.5%
净利率更高
ENSC
高出397.1%
-544.1%
两年增速更快
ENSC
近两年复合增速
-25.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0M | $1.9M |
| 净利润 | $-5.6M | $-2.8M |
| 毛利率 | 86.9% | — |
| 营业利润率 | -576.9% | -147.8% |
| 净利率 | -544.1% | -147.0% |
| 营收同比 | -38.5% | 44.4% |
| 净利润同比 | -56.7% | 22.3% |
| 每股收益（稀释后） | — | $-0.51 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CXAIENSC
| Q4 25 | $1.0M | $1.9M | ||
| Q3 25 | $1.1M | $493.1K | ||
| Q2 25 | $1.2M | $1.4M | ||
| Q1 25 | $1.2M | $1.3M | ||
| Q4 24 | $1.7M | $1.3M | ||
| Q3 24 | $1.9M | $3.4M | ||
| Q2 24 | $1.8M | — | ||
| Q1 24 | $1.8M | — |
净利润CXAIENSC
| Q4 25 | $-5.6M | $-2.8M | ||
| Q3 25 | $-3.2M | $-3.7M | ||
| Q2 25 | $-3.1M | $-1.7M | ||
| Q1 25 | $-1.6M | $-1.9M | ||
| Q4 24 | $-3.5M | $-3.6M | ||
| Q3 24 | $-5.4M | $661.8K | ||
| Q2 24 | $-5.3M | — | ||
| Q1 24 | $-5.2M | — |
毛利率CXAIENSC
| Q4 25 | 86.9% | — | ||
| Q3 25 | 89.0% | — | ||
| Q2 25 | 86.0% | — | ||
| Q1 25 | 87.7% | — | ||
| Q4 24 | 86.0% | — | ||
| Q3 24 | 80.4% | — | ||
| Q2 24 | 80.0% | — | ||
| Q1 24 | 82.0% | — |
营业利润率CXAIENSC
| Q4 25 | -576.9% | -147.8% | ||
| Q3 25 | -343.4% | -758.7% | ||
| Q2 25 | -336.1% | -127.6% | ||
| Q1 25 | -306.0% | -149.1% | ||
| Q4 24 | -169.7% | -274.3% | ||
| Q3 24 | -194.3% | 18.9% | ||
| Q2 24 | -206.7% | — | ||
| Q1 24 | -197.3% | — |
净利率CXAIENSC
| Q4 25 | -544.1% | -147.0% | ||
| Q3 25 | -283.4% | -756.3% | ||
| Q2 25 | -256.7% | -126.4% | ||
| Q1 25 | -132.0% | -147.4% | ||
| Q4 24 | -213.6% | -273.4% | ||
| Q3 24 | -286.5% | 19.4% | ||
| Q2 24 | -297.6% | — | ||
| Q1 24 | -284.4% | — |
每股收益（稀释后）CXAIENSC
| Q4 25 | — | $-0.51 | ||
| Q3 25 | — | $-1.29 | ||
| Q2 25 | — | $-0.79 | ||
| Q1 25 | — | $-1.39 | ||
| Q4 24 | — | $-0.89 | ||
| Q3 24 | — | $1.00 | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.1M | $4.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $14.0M | $3.2M |
| 总资产 | $32.4M | $7.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CXAIENSC
| Q4 25 | $11.1M | $4.3M | ||
| Q3 25 | $5.1M | $1.7M | ||
| Q2 25 | $4.9M | $2.2M | ||
| Q1 25 | $3.9M | $3.1M | ||
| Q4 24 | $4.9M | $3.5M | ||
| Q3 24 | — | $4.2M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CXAIENSC
| Q4 25 | $14.0M | $3.2M | ||
| Q3 25 | $15.2M | $1.2M | ||
| Q2 25 | $14.3M | $3.4M | ||
| Q1 25 | $15.6M | $3.0M | ||
| Q4 24 | $15.6M | $3.7M | ||
| Q3 24 | $13.6M | $6.9M | ||
| Q2 24 | $16.3M | — | ||
| Q1 24 | $20.9M | — |
总资产CXAIENSC
| Q4 25 | $32.4M | $7.5M | ||
| Q3 25 | $28.5M | $3.2M | ||
| Q2 25 | $29.6M | $5.6M | ||
| Q1 25 | $29.3M | $4.6M | ||
| Q4 24 | $31.8M | $5.6M | ||
| Q3 24 | — | $9.4M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.6M | $-1.5M |
| 自由现金流经营现金流 - 资本支出 | $-3.6M | — |
| 自由现金流率自由现金流/营收 | -355.5% | — |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-10.4M | — |
8季度趋势，按日历期对齐
经营现金流CXAIENSC
| Q4 25 | $-3.6M | $-1.5M | ||
| Q3 25 | $-2.8M | $-1.9M | ||
| Q2 25 | $-3.0M | $-2.7M | ||
| Q1 25 | $-979.0K | $-1.7M | ||
| Q4 24 | $-2.7M | $-764.1K | ||
| Q3 24 | $-2.1M | $-1.0M | ||
| Q2 24 | $-1.9M | — | ||
| Q1 24 | $-650.0K | — |
自由现金流CXAIENSC
| Q4 25 | $-3.6M | — | ||
| Q3 25 | $-2.8M | — | ||
| Q2 25 | $-3.0M | — | ||
| Q1 25 | $-984.0K | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-2.1M | — | ||
| Q2 24 | $-1.9M | — | ||
| Q1 24 | $-668.0K | — |
自由现金流率CXAIENSC
| Q4 25 | -355.5% | — | ||
| Q3 25 | -248.1% | — | ||
| Q2 25 | -247.2% | — | ||
| Q1 25 | -80.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -109.3% | — | ||
| Q2 24 | -108.6% | — | ||
| Q1 24 | -36.7% | — |
资本支出强度CXAIENSC
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 1.0% | — |
现金转化率CXAIENSC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -1.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
